NCIt definition : An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential
antineoplastic activity. c-Met inhibitor JNJ-38877605 selectively inhibits c-Met,
a receptor tyrosine kinase (RTK) involved in cancer cell survival and invasiveness,
and tumor angiogenesis. c-Met is also known as hepatocyte growth factor receptor (HGFR).;
UNII : 15UDG410PN;
CAS number : 943540-75-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 943540-75-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;